The manufacturer of the ill-reputed contraceptive drug Yaz released a quarterly report in July that highlighted current Yaz and Yasmin litigation. According to Bayer’s report, there are around 5,000 Yaz and Yasmin lawsuits pending in the United States. In addition, Bayer reported that they arrived at a settlement agreement in early July 2014 that would affect nearly 9,000 lawsuits.
The settlement amount is for $1.8 billion. Under this particular Yaz settlement, only those cases involving venous thromboembolism, or the formation of blood clots, qualify to be considered for compensation.
Yaz and Yasmin, and the generic alternative, Ocella, have all gained the reputation of causing serious health complications, among them blood clots. Yaz, Yasmin, and Ocella contain a hormone called drospirenone which has been connected to an increased risk in the formation of blood clots.
Carey Danis & Lowe is a St. Louis law firm that provides expert legal representation to victims in defective drug litigation. Our attorneys are currently representing victims of Yaz, Yasmin, and Ocella, and are accepting cases.
If you or someone you love has been injured by Yaz, Yasmin, or Ocella, Carey Danis & Lowe encourages you to evaluate your options and compensation eligibility with us today in a free legal consultation.
Share your Yaz story with Carey Danis & Lowe today. We are available to listen to you. Call our law firm at 800.721.2519, or contact us by submitting a confidential personal injury claim form.References: Pharmaceutical litigation, Yaz/Yasmin